Suven Life Sciences: Board Meeting Intimation for To Consider And Approve Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half-Year Ended September 30 2025 And Related Matters

Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half-year ended September 30 2025 and related matters